Added Value of Local Clonidine for Spine Postoperative Pain Control, in Addition to Bupivacaine
Information source: St Joseph University, Beirut, Lebanon
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Post-operative Pain
Intervention: Bupivacaine (Drug); Clonidine (Drug)
Phase: Phase 4
Status: Recruiting
Sponsored by: St Joseph University, Beirut, Lebanon Official(s) and/or principal investigator(s): Joseph Maarrawi, MD, PhD, Principal Investigator, Affiliation: Laboratory of neurosciences, Faculty of medicine, St Joseph University of Beirut
Summary
The objective of this prospective randomized double-blind study is to evaluate the added
analgesic value of clonidine to the conventional local bupivacaine wound infiltration in
posterior spine surgery.
Clinical Details
Official title: Randomized Double-blind Trial Comparing the Post-operative Analgesic Efficacy of Local Wound Infiltration With Bupivacaine Alone to Bupivacaine With Clonidine in Posterior Spine Surgeries
Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Outcomes Assessor), Primary Purpose: Treatment
Primary outcome: Mean Area under curve
Secondary outcome: Area under Curve (AUC) of painDaily rescue opiates consumption Global subjective patient satisfaction of post-operative wound pain control
Detailed description:
Patients candidates to posterior spine surgery (Micro-discectomy, Lumbar laminectomy with or
without fusion, cervical laminectomy) are asked to participate to this prospective study.
After verification of inclusion and exclusion criteria, patients consenting to enter the
study are randomly assigned to one of the following subgroups: 1-Pre-incisional wound
infiltration with 20 mL of bupivacaine 0. 25%. 2- Pre-incisional wound infiltration
with 150 μg of clonidine with 20 mL of bupivacaine 0. 25%. Demographic parameters,
co-morbidities and other pre and per operative medical data are noted. In the post-operative
period, patients received a standardized post-operative analgesic protocol (NSAI and
paracetamol). Patients are asked to fill their pain diary using Visual Analog Scale (VAS)
from day 0 till day 8 after surgery. Morphine rescue consumption is noted. Finally, the
percentage of global subjective patient satisfaction regarding the post-operative wound pain
is noted from 0 to 100.
Eligibility
Minimum age: 18 Years.
Maximum age: 72 Years.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- First (not recurrent) posterior spinal surgery at the operated site
- American Society of Anesthesiologists class I or II (operative risk)
Exclusion Criteria:
- Allergy to local anesthetics or to clonidine
- Pregnancy
- Raynaud's syndrome
- Thromboangiitis obliterans
- History of substance abuse
- Current treatment with corticosteroids
Locations and Contacts
Hotel Dieu de france Hospital, Beirut 16-6830, Lebanon; Recruiting Joseph Maarrawi, MD, PhD, Phone: 009611615300, Ext: 9513, Email: joseph.maarrawi@usj.edu.lb Joseph Maarrawi, MD, PhD, Principal Investigator
Additional Information
Starting date: January 2013
Last updated: May 22, 2015
|